Skin, immunity and the nervous system

British Journal of Dermatology

Volumn 137, Issue 6, 1997, Pages 843-850

  Misery, L ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CATECHOLAMINE DERIVATIVE; CORTICOTROPIN; ENDORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; GASTRIN RELEASING PEPTIDE; INTERMEDIN; NEUROHORMONE; NEUROKININ A; NEUROKININ B; NEUROPEPTIDE Y; NEUROTENSIN; PEPTIDE HISTIDINE ISOLEUCINE; PROLACTIN; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; NERVOUS SYSTEM; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN; SKIN NERVE;

EID: 0031451675     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01542.x     Document Type: Review

References (89)

1. Stead RH. Innervation of mucosal immune cells in gastrointestinal tract. Regional Immunol 1992; 4: 91-9.
2. Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol 1995; 33: 482-96.
3. Staniek V, Misery L. Neuromédiateurs en immunobiologie cutanée. Nouv Dermatol 1996; 15: 28-35.
4. Gaudillère A, Misery L, Bernard C et al. Presence of somatostatin in normal human epidermis. Br J Dermatol 1997; 137: 376-380.
5. Eedy DJ, Shaw C, Johnston CF, Buchanan KD. The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 1994; 19: 463-72.
6. MacGovern UB, Jones KT, Sharpe GR. Intracellular calcium as a second messenger following growth stimulation of human keratinocytes. Br J Dermatol 1995; 132: 892-6.
7. Misery L, Claudy A. Interactions des neuromédiateurs et neurohormones sur les cellules dendritiques, les monocytes et les macrophages (hors système nerveux central). Pathol Biol 1995; 43: 876-81.
8. Di Marco E, Marchisio PC, Bondanza S et al. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991; 266: 21718-22.
9. Yaar M, Grossman K, Eller M, Gilchrest B. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 1991; 115: 821-8.
10. Narisawa Y, Hashimoto K, Nihei Y, Pietruk T. Biological significance of dermal Merkel cells in development of cutaneous nerves in human fetal skin. J Histochem Cytochem 1992; 40: 65-71.
11. Pincelli C, Sevignani C, Manfredini R et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994; 103: 13-18.
12. Wilkinson DI, Theuwes MJ, Farber EM. Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: a comparison with epidermal growth factor. Exp Dermatol 1994; 3: 239-45.
13. Zhai S, Pincelli C, Yaar M et al. The role of nerve growth factor in preventing keratinocyte apoptosis. J Invest Dermatol 1995; 105: 572.
14. Yaar M, Zhai S, Pincelli C, Gilchrest BA. A dual role for p75 nerve growth factor receptor in melanocyte survival and apoptosis. J Invest Dermatol 1995; 104: 585.
15. Moll I, Hartscuh W, Moll R. First International Merkel Symposium. Heidelberg, Germany. J Invest Dermatol 1995; 105: 851-5.
16. Gaudillère A, Misery L. La cellule de Merkel. Ann Dermatol Venereol 1994; 121: 909-17.
17. Misery L, Gaudillère A, Cellule de Merkel et neuromédiateurs. In: Biologie de la Peau (Schmitt D, ed.). Editions INSERM. 1995; 147-56.
18. Yamashita Y, Akaïne N, Wakamori M et al. Voltage-dependent currents in isolated single Merkel cells of rat. J Physiol 1992; 450: 143-62.
19. Hartschuh W, Weihe E. Multiple messenger candidates and marker substances in the mammalian Merkel cell-axon complex: a light and electron microscopic immunohistochemical study. Prog Brain Res 1988; 74: 181-7.
20. Ortonne JP, Petchot-Baque JP, Verrando P et al. Normal Merkel cells express a synaptophysin-like immunoreactivity. Dermatologica 1988; 177: 1-10.
21. Cocchia D, Michetti F, Donato R. Immunochemical and immunocytochemical localization of S-100 antigen in normal human skin. Nature 1981; 294: 85-7.
22. Misery L, Campos L, Sabido O et al. S100 protein and neuron specific enolase on monocytic leukemic CD1+ cells, probable precursors of Langerhans cells. Eur J Haematol 1993; 51: 1132-5.
23. Hsieh ST, Choi S, Lin WM et al. Epidermal denervation and its effects on keratinocytes and Langerhans cells. J Neurocytol 1996; 25: 513-24.
24. Bhardwaj RS, Luger TA. Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch Dermatol Res 1994; 287: 85-90.
25. Hosoi J, Murphy GF, Egan CL et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1995; 363: 159-65.
26. Staniek V, Misery L, Péguet-Navarro J et al. Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch Dermatol Res 1997; 289: 285-91.
27. Staniek V, Misery L, Péguet-Navarro J et al. Expression of gastrin releasing peptide-receptor in human skin. Acta Dermatol Venereol 1996; 76: 282-6.
28. Shimizu T, Streilein JW. Influence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 1994; 8: 187-93.
29. Pincelli C, Fantini F, Massimi P, Gianetti A. Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis. J Neurosci 1990; 51: 219-20.
30. Grando SA, Kist DA, Qi M, Dahl M. Human keratinocytes synthesize, secrete and degrade acetylcholinc. J Invest Dermatol 1993; 101: 32-6.
31. Schallreuter KU, Wood JM, Lemke R et al. Production of catecholamines in the human epidermis. Biochem Biophys Res Commun 1992; 189: 72-8.
32. Arenberger P, Leder RO, Abraham A et al. Substance P binding in normal neonatal foreskin. Br J Dermatol 1995; 132: 54-8.
33. Kemeny L, Von Restoff B, Michel G, Ruzicka T. Specific binding and lack of growth-promoting activity of substance P in cultured human keratinocytes. J Invest Dermatol 1994; 103: 605-6.
34. Pincelli C, Fantini F, Giardino L et al. Autoradiographic detection of substance P receptors in normal and psoriatic skin. J Invest Dermatol 1993; 101: 301-4.
35. Takahashi K, Nakanishi S, Imamura S. Direct effects of cutaneous neuropeptides on adenyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol 1993; 101: 646-51.
36. Grando SA, Zelickson BD, Kist DA et al. Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol 1995; 104: 95-100.
37. Grando SA, Horton RM, Pereira EFR et al. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995; 105: 774-81.
38. Chakraborty A, Slominski A, Ermak G et al. Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for αMSH receptors and propiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dermatol 1995; 105: 655-9.
39. Schallreuter KU, Wood JM, Pittelkow MR et al. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res 1996; 288: 14-18.
40. Almeida ALM, Markus RP, Visconti MA, Castrucci AML. Presence of melatonin binding sites in S-91 murine melanoma cells. Pigment Cell Res 1995; 10: 31.
41. Schallreuter KU, Körner C, Pittelkow MR et al. The induction of the α-1-adrenoreceptor signal transduction system on human melanocytes. Exp Dermatol 1996; 5: 20-3.
42. Gaudillère A, Misery L, Rousselle P et al. Expression of somatostatin receptors on dermal fibroblasts. J Invest Dermatol 1995; 105: 499.
43. Arner P. The β3 adrenergic receptor. A cause and cure of obesity? N Engl J Med 1995; 333: 382-3.
44. Wang L, Hilliges M, Jernberg T et al. Protein gene product 9.5-immunoreactive nerve fibers and cells in human skin. Cell Tissue Res 1990; 261: 25-33.
45. Hilliges M, Hellman M, Ahlström U, Johansson O. Immunohistochemical studies of neurochemical markers in normal human buccal mucosa. Histochemistry 1994; 101: 235-44.
46. Merkel F. Tastzellen und Tastkorperchen bei den Haustieren und beim Menschen. Arch Microsc Anat 1875; 11: 636-52.
47. Hatschuh W, Weihe E. Fine structural analysis of the synaptic junction of Merkel cell-axon complexes. J Invest Dermatol 1980; 75: 159-65.
48. Langerhans P. Über die Nerven der Menschlichen Haut. Virchows Arch Pathol Anat Physiol 1868; 44: 325-37.
49. Gaudillère A, Misery L, Souchier C et al. Intimate associations between Langerhans cells and nerve fibres. Br J Dermatol 1996; 135: 343-4.
50. Hilliges M, Wang L, Johansson O. Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermatol 1995; 104: 134-7.
51. Hara M, Toyoda M, Yaar M et al. Innervation of melanocytes in human skin. J Exp Med 1996; 184: 1385-95.
52. Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnestski BM. Electron microscopal evidence for a direct contact between nerve fibers and mast cells. Acta Derm Venereol (Stockh) 1981; 61: 465-9.
53. Sueki H, Telegan B, Murphy GF. Computer-assisted three-dimensional reconstruction of human dermal dendrocytes. J Invest Dermatol 1995; 105: 704-8.
54. Chédotal A, Hamel E. L'innervation cholinergique de la paroi vasculaire. Méd/Sci 1993; 9: 1035-42.
55. Diamond J, Holmes M, Nurse CA. Are Merkel cell-neurite reciprocal synapses involved in the initiation of tactile responses in salamander skin? J Physiol 1986; 376: 101-20.
56. Morohunfola KA, Jones TE, Munger BL. The differentiation of the skin and its appendages. I. Normal development of papillary ridges. II. Altered development of papillary ridges following neuralectomy. Anat Rec 1992; 232: 587-611.
57. Narisawa Y, Kohda H. Merkel cells do not require trophic maintenance from the nerves in adult human skin. Br J Dermatol 1995; 133: 553-6.
58. Nikkels-Tassoudji N, Nikkels AF, Pierard GE. Neuropeptides cutanés. Nouv Dermatol 1994; 13: 767-72.
59. Homo-Delarche F, Durant S. Hormones, neurotransmitters and neuropeptides as modulators of lymphocyte functions. In: Immunopharmacology of Lymphocytes (Rola-Pleszczynski M, ed.). London: Academic Press, 1994; 171-240.
60. Misery L, Staniek V. Neuromédiateurs et immunité cutanée. In: 7ème Cours de Biologie de la Peau (Thivolet J, Schmitt D, eds). Editions INSERM, 1993; 197-211.
61. Savino W, Dardenne M. Immune-neuroendocrine interactions. Immunol Today 1995; 16: 318-22.
62. Asahina A, Moro O, Hosoi J et al. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc Natl Acad Sci USA 1995; 92: 8323-7.
63. Gillardon F, Moll I, Michel S et al. Calcitonin gene-related peptide and nitric oxide are involved in ultraviolet radiation-induced immunosuppression. Eur J Pharmacol-Environ Toxic 1995; 293: 395-400.
64. Hosoi J, Torii H, Fox F et al. Alteration of cytokine expression by calcitonin gene-related peptide (CGRP). J Invest Dermatol 1995; 105: 859.
65. Asahina A, Hosoi J, Beissert S et al. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995; 154: 3056-61.
66. Clauseno PF, Thoruid E, Iversen OH. Adrenalin has differential effects on epidermal cell cycle progression in mice. J Invest Dermatol 1982; 78: 472-6.
67. Schallreuter KU, Lemke KR, Pittelkow MR et al. Catecholamines in human keratinocyte differentiation. J Invest Dermatol 1995; 104: 953-7
68. Paus R, Heinzelmann T, Robiseck S et al. Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res 1995; 287: 500-2.
69. Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of keratinocytes. J Invest Dermatol 1988; 90: 399-401.
70. Pincelli C, Fantini F, Romulaldi P et al. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 1992; 98: 421-7.
71. Viac J, Guéniche A, Doutremepuich JD et al. Substance P and keratinocyte activation markers: an in vitro approach. Arch Dermatol Res 1996; 288: 85-90.
72. Coutant KD, Ryder NS. Bradykinin upregulates immediate-early mRNA in human keratinocytes. Arch Dermatol Res 1996; 288: 2-6.
73. Mazzetti M, Mozzetta A, Soavi GC et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol (Stockh) 1994; 186 (Suppl.): 62-4.
74. Pincelli C, Fantini F, Magnoni C, Giannetti A. Psoriasis and the nervous system. Acta Derm Venereol (Stockh) 1994; 186 (Suppl.): 60-1.
75. Al'Abadie MSK, Senior HJ, Bleheen SS, Gawkrodger DJ. Neuropeptides and general neuronal marker in psoriasis - an immunohistochemical study. Clin Exp Dermatol 1995; 20: 384-9.
76. Fantini F, Magnoni C. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 1995; 105: 854-5.
77. Glinski W, Brodecka H, Glinska-Frerenz M, Koxalki D. Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 1994; 131: 260-4.
78. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-37.
79. Tobin D, Nabarro G, De La Faille HB et al. Increased number of nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992; 90: 613-22.
80. Pincelli C, Fantini F, Massimi P et al. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990; 122: 745-50.
81. Johansson O, Liu PY, Han SW et al. An immunohistochemical study of neuroactive substances in the skin of atopic dermatitis. Eur J Dermatol 1995; 5: 516-23.
82. Rupprecht M, Renders U, Koch HU, Hornstein OP. Twenty-four hour secretion of prolactin in patients with atopic eczema and normal controls. Eur J Dermatol 1993; 3: 495-8.
83. Abadia-Molina F, Burrows NP, Russel-Jones R et al. Increased sensory neuropeptides in nodular prurigo: a quantitative immunochemical analysis. Br J Dermatol 1992; 127: 344-51.
84. Al'Abadie MSK, Senior HJ, Blechen SS, Gawkrodger DJ. Neuronal marker and neuropeptide studies in nodular prurigo. Eur J Dermatol 1994; 4: 154-8.
85. Morohashi M, Hashimoto K, Goodman F. Ultrastructural studies of vitiligo, Vogt-Koyanagi-Harada syndrome and incontinentia pigmenti achromians. Arch Dermatol 1977; 113: 755-66.
86. Gauthier Y. The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions. Eur J Dermatol 1995; 5: 704-8.
87. Al'Abadie MSK, Warren MA, Bleehen SS, Gawkrodger DJ. Morphologic observations on the dermal nerves in vitiligo: an ultrastructural study. Int J Dermatol 1995; 34: 837-40.
88. Al'Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 1994; 131: 160-5.
89. Staniek V, Misery L. Doutremepuich JD et al. Expression of substance P-receptors in normal skin and psoriasis. J Invest Dermatol 1997; 109: 456.